Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01WLB
|
|||
| Former ID |
DIB006090
|
|||
| Drug Name |
Lu-AA39959
|
|||
| Indication | Bipolar disorder [ICD-11: 6A60; ICD-10: F31] | Phase 2 | [1] | |
| Company |
H Lundbeck A/S
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Ion channel unspecific (IC) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00771134) Efficacy and Safety of Lu AA39959 in Patients With Bipolar Depression. U.S. National Institutes of Health. | |||
| REF 2 | Lundbeck: leading the way in the treatment of CNS disorders. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.